Pioneering Medical Innovations
Acquisition expands portfolio of men’s health in-office procedures with adjunctive therapy for prostate cancer patients Sep 6, 2018 MARLBOROUGH, Mass., Sept.
Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation.
Boston Scientific (NYSE:BSX) said today it inked a deal worth up to $300 million to acquire Apama Medical and its radiofrequency balloon catheter system designed to treat atrial fibrillation.
“With AccessClosure we received an outstanding management team with a proven track record to commercialize interventional cardiology assets,” Don Casey,
Novel Platform Based Technology Combines Multiple Functions in Single Device; Acquisition includes Portfolio of FDA 510(k) Cleared Catheters for Dialysis
May 9, 2012 – Still riding an acquisition wave, global healthcare products provider Covidien (NYSE: COV) has acquired nascent hypertension
NATICK, Mass., Jan. 4, 2011 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced the completion of its acquisition of
–Next-Generation Abdominal Aortic Aneurysm Technology Expected to Expand Global Market –Company to Build European Direct Sales Force in Anticipation of
Strategic acquisition to expand Cognizant’s Life Sciences industry offerings PRNewswire-FirstCall – TEANECK, N.J. Cognizant Technology Solutions Corporation (NASDAQ: CTSH), a
Acquisition demonstrates Company’s commitment to leadership in treating carotid artery disease PRNewswire-FirstCallNATICK, Mass.(NYSE:BSX)Jan 4, 2007 NATICK, Mass., Jan. 4 /PRNewswire-FirstCall